Fennec Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Business Update

Go back to Fennec Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Business Update

Fennec Pharmaceuticals (FENC) Misses Q2 EPS by 6c

August 12, 2022 7:04 AM EDT

Fennec Pharmaceuticals (NASDAQ: FENC) reported Q2 EPS of ($0.19), $0.06 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.

... More